Prostate cancer

News

Halda Therapeutics' president and chief executive, Christian Schade

J&J swoops on cancer biotech Halda with $3bn takeover deal

Johnson & Johnson has added to the flurry of M&A deals in pharma with an agreement to buy Halda Therapeutics and its RIPTAC anticancer platform.

News

"Significant shift" as NICE widens prostate cancer drug use

NICE has changed unpopular guidance on abiraterone for hormone-sensitive prostate cancer after the entry of generics into the UK market.

News

Blue ribbon for prostate cancer awareness

As UK mulls prostate cancer screening, study shows benefit

New data have shown that the balance between the benefits and harms of prostate cancer screening has improved with longer follow-up.

News

As Blenrep returns, GSK adds another ADC to cancer pipeline

GSK has boosted its pipeline of antibody-drug conjugates for cancer, licensing a prostate cancer candidate from Syndivia.

News

A male HCP discusses treatment with an older male patient

Bayer's prostate cancer drug Nubeqa cleared for NHS use

Thousands of men living with incurable prostate cancer will be able to access an easier-to-tolerate treatment from Bayer, thanks to new NICE guidance.

Oncology

Interview at ESMO 2025 with Nicoletta Brega and Christine Roth from Bayer

J&J swoops on cancer biotech Halda with $3bn takeover deal

"Significant shift" as NICE widens prostate cancer drug use

As UK mulls prostate cancer screening, study shows benefit

As Blenrep returns, GSK adds another ADC to cancer pipeline

Bayer's prostate cancer drug Nubeqa cleared for NHS use

ESMO25: The importance of personalisation, with Bayer’s Dr N...

LSX2026: On promise and patience, with Hans Schambye

Using AI-driven synthetic personas to take your insights fur...

Prostate cancer

Editor's Picks